01. Executive Summary 02. List of Abbreviations 03. Introduction 04. Market Research Methodology Market Research Process Research Design Research Methodology 05. Scope of the Report Market Overview Product Offerings 06. Market Landscape 06.1 Global HAMarket Market Size and Forecast 06.2 HA Market in the US Market Size and Forecast 06.3 Market Segmentation by Product Type 06.4 Five Forces Analysis 07. Geographical Segmentation 08. Key Leading Countries USA Japan 09. Vendor Landscape 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Key Vendor Analysis 16.1 FerringPharmacuticals Inc. Business Overview Key Information SWOT Analysis 16.2 FidiaFarmaceuticiSpA Business Overview Key Information SWOT Analysis 16.3 Sanofi SA Business Overview Key Information SWOT Analysis 16.4 Seikagaku Corp. Business Overview Key Information SWOT Analysis 17. Other Reports in this Series List of Exhibits Exhibit 1: Market Research Methodology Exhibit 2: Global HA Market 2012-2016 (US$ billion) Exhibit 3: HA Market in the US 2012-2016 (US$ billion) Exhibit 4: Global HA Market Segmentation based on Product Type Exhibit 5: Business Segmentation of Ferring Pharmaceuticals Inc. Exhibit 6: Business Segmentation of FidiaFarmaceuticiSpA Exhibit 7: Business Segmentation of Sanofi SA Exhibit 8: Business Segmentation of Seikagaku Corp.

Ferring Pharmaceuticals Inc., Fidia farmaceutici SpA, Sanofi SA and Seikagaku Corp., Anika Therapeutics Inc., Contipro Biotech Sro, htl BIOTECHNOLOGY, Lifecore Biomedical LLC, Shandong Freda Biochem Co. Ltd, Teijin Pharma Ltd., TRB Chemedica International SA and Novozymes A/S.